All translations

Jump to navigation Jump to search

Enter a message name below to show all available translations.

Message

Found 2 translations.

NameCurrent message text
 h English (en)==ACE inhibitors==
[[File:Captopril skeletal.svg|thumb|[[Captopril]], the prototypical ACE inhibitor]]
[[ACE inhibitor]]s inhibit the activity of [[angiotensin-converting enzyme]] (ACE), an enzyme responsible for the conversion of angiotensin I into [[angiotensin]] II, a potent [[vasoconstrictor]].
* [[captopril]]
* [[enalapril]]
* [[fosinopril]]
* [[lisinopril]]
* [[moexipril]]
* [[perindopril]]
* [[quinapril]]
* [[ramipril]]
* [[trandolapril]]
* [[benazepril]]
A systematic review of 63 trials with over 35,000 participants indicated ACE inhibitors significantly reduced doubling of serum creatinine levels compared to other drugs (ARBs, α blockers, β blockers, etc.), and the authors suggested this as a first line of defense. The AASK trial showed that ACE inhibitors are more effective at slowing down the decline of [[kidney function]] compared to [[calcium channel blockers]] and [[beta blockers]]. As such, ACE inhibitors should be the drug treatment of choice for patients with [[chronic kidney disease]] regardless of race or diabetic status.
 h Japanese (ja)==ACE阻害薬==
{{Anchor|ACE inhibitors}}
[[File:Captopril skeletal.svg|thumb|[[Captopril/ja|カプトプリル]]、代表的なACE阻害薬]]
[[ACE inhibitor/ja|ACE阻害薬]]は、アンジオテンシンIから強力な[[vasoconstrictor/ja|血管収縮物質]]である[[angiotensin/ja|アンジオテンシン]]IIへの変換を担う酵素である[[angiotensin-converting enzyme/ja|アンジオテンシン変換酵素]](ACE)の活性を阻害する。
* [[captopril/ja]]
* [[enalapril/ja]]
* [[fosinopril/ja]]
* [[lisinopril/ja]]
* [[moexipril/ja]]
* [[perindopril/ja]]
* [[quinapril/ja]]
* [[ramipril/ja]]
* [[trandolapril/ja]]
* [[benazepril/ja]]
35,000人以上が参加した63の試験のシステマティックレビューでは、ACE阻害薬は他の薬物(ARB、α遮断薬、β遮断薬など)に比べて血清クレアチニン値の倍加を有意に抑制することが示され、著者らはこれを第一選択薬として推奨している。AASK試験では、ACE阻害薬は[[calcium channel blockers/ja|カルシウム拮抗薬]]や[[beta blockers/ja|β遮断薬]]に比べて[[kidney function/ja|腎機能]]の低下を遅らせる効果があることが示された。そのため、ACE阻害薬は人種や糖尿病の有無にかかわらず、[[chronic kidney disease/ja|慢性腎臓病患者]]に選択されるべき薬物治療である。